Financial Advantage, Inc. Spdr Ser Tr Spdr S&P Biotech E Transaction History

Financial Advantage, Inc.

$65.1 Million
Q3 2023

A detailed history of Financial Advantage, Inc. transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Financial Advantage, Inc. holds 22,737 shares of XBI stock, worth $2.09 Million. This represents 2.55% of its overall portfolio holdings.

Number of Shares

22,737

Previous 37,164 38.82%

Holding current value

$2.09 Million

Previous $3.09 Million 46.31%

% of portfolio

2.55%

Previous 2.77%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$71.88 - $85.76 $1.04 Million - $1.24 Million	-14,427 Reduced 38.82%	22,737 $1.66 Million
Q2 2023 Aug 08, 2023	BUY	$75.38 - $90.23 $53,142 - $63,612	705 Added 1.93%	37,164 $3.09 Million
Q1 2023 May 03, 2023	SELL	$73.13 - $91.97 $7,678 - $9,656	-105 Reduced 0.29%	36,459 $2.78 Million
Q4 2022 Jan 26, 2023	BUY	$76.72 - $85.66 $8,439 - $9,422	110 Added 0.3%	36,564 $0
Q3 2022 Oct 25, 2022	SELL	$75.06 - $94.9 $1,426 - $1,803	-19 Reduced 0.05%	36,454 $2.89 Million
Q2 2022 Aug 01, 2022	BUY	$62.81 - $96.09 $59,669 - $91,285	950 Added 2.67%	36,473 $2.71 Million
Q1 2022 May 09, 2022	BUY	$81.07 - $115.44 $1.82 Million - $2.6 Million	22,482 Added 172.39%	35,523 $3.19 Million
Q4 2021 Jan 26, 2022	BUY	$108.77 - $134.15 $652 - $804	6 Added 0.05%	13,041 $1.46 Million
Q3 2021 Nov 10, 2021	BUY	$118.69 - $138.49 $25,043 - $29,221	211 Added 1.65%	13,035 $1.64 Million
Q2 2021 Aug 04, 2021	SELL	$122.48 - $139.69 $18,004 - $20,534	-147 Reduced 1.13%	12,824 $1.74 Million
Q1 2021 May 04, 2021	BUY	$129.36 - $173.99 $102,582 - $137,974	793 Added 6.51%	12,971 $1.76 Million
Q4 2020 Feb 10, 2021	SELL	$110.36 - $151.14 $139,384 - $190,889	-1,263 Reduced 9.4%	12,178 $1.71 Million
Q3 2020 Oct 27, 2020	SELL	$103.87 - $120.36 $840,723 - $974,193	-8,094 Reduced 37.59%	13,441 $1.5 Million
Q2 2020 Aug 07, 2020	SELL	$73.26 - $114.17 $61,758 - $96,245	-843 Reduced 3.77%	21,535 $2.41 Million
Q1 2020 Apr 27, 2020	BUY	$65.95 - $98.35 $427,224 - $637,111	6,478 Added 40.74%	22,378 $1.73 Million
Q4 2019 Jan 31, 2020	SELL	$74.65 - $98.46 $1,194 - $1,575	-16 Reduced 0.1%	15,900 $1.51 Million
Q3 2019 Oct 23, 2019	BUY	$76.25 - $83.86 $43,233 - $47,548	567 Added 3.69%	15,916 $1.21 Million
Q2 2019 Jul 23, 2019	BUY	N/A	93 Added 0.61%	15,349 $1.35 Million
Q1 2019 Apr 17, 2019	SELL	N/A	-19 Reduced 0.12%	15,256 $1.38 Million
Q4 2018 Jan 30, 2019	SELL	N/A	-108 Reduced 0.7%	15,275 $1.1 Million
Q3 2018 Oct 31, 2018	BUY	N/A	1,340 Added 9.54%	15,383 $1.48 Million
Q2 2018 Jul 30, 2018	BUY	N/A	495 Added 3.65%	14,043 $1.34 Million
Q1 2018 May 10, 2018	SELL	N/A	-406 Reduced 2.91%	13,548 $1.19 Million
Q4 2017 Feb 07, 2018	BUY	N/A	329 Added 2.41%	13,954 $1.18 Million
Q3 2017 Nov 14, 2017	BUY	N/A	268 Added 2.01%	13,625 $1.18 Million
Q2 2017 Aug 11, 2017	BUY	N/A	13,357	13,357 $1.03 Million

Others Institutions Holding XBI

# of Institutions

927

Shares Held

101M

Call Options Held

28.4M

Put Options Held

33.4M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advantage, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Advantage, Inc. with notifications on news.

Account

Financial Advantage, Inc. Spdr Ser Tr Spdr S&P Biotech E Transaction History